The importance of ancestry to understanding tumor mutation burden in cancer

New paper

In a new paper, Nassar and colleagues find that in solid tumors, tumor-only sequencing leads to an overestimate of the biomarker tumor mutation burden (TMB), particularly in patients of African or Asian ancestry. Correction of the TMB estimate improves the correlation between TMB and response to immunotherapy. Paper in Cancer Cell

Previous post
Multimodal data fusion improves prognostic models for a majority of cancer types Next post
Acquired semi-squamatization during chemotherapy suggests differentiation as a therapeutic strategy for bladder cancer